Now that the federal government has finally released its quality ratings for more than 5,500 U.S. dialysis facilities, it's time to move on and work within the system—even if the system is flawed, says DaVita Kidney Care CEO Javier Rodriguez.
Healthcare expenses appear to have climbed at a brisk pace, backing previous calculations that the healthcare industry remains a force even during an otherwise lackluster quarter.
The Cleveland Clinic's surplus boomed in the first quarter of 2015, as the not-for-profit system saw more Medicaid-eligible patients and grew its long-term investments.
Pittsburgh-based UPMC must continue to provide in-network services to members of Highmark's Medicare Advantage plans per the terms of an earlier agreement signed by the two feuding organizations, a Pennsylvania judge ruled Friday.
Health insurer Humana, Louisville, Ky., is reportedly working with an investment bank to explore a sale. Humana, one of the largest Medicare Advantage insurers in the country, has been a rumored takeover target for more than a year.
Medical device makers, facing reimbursement and sales pressure in the U.S., are looking to China for opportunities as globalization becomes a key part of their strategy.
Amedisys, one of the nation's largest home health and hospice providers, is under investigation by the U.S. Justice Department, the company revealed in a filing with the Securities and Exchange Commission on Thursday.
The CMS is expected to issue final regulations soon that could significantly affect whether hospitals and doctors remain willing to participate in Medicare's accountable care program.
NextCare Holdings, a Mesa, Ariz.-based urgent-care and occupational medical services provider, has acquired three new facilities in Arizona, allowing it to provide care to more than 90% of the state's population.
A jury has ordered Boston Scientific to pay $100 million to a woman who, despite two surgeries, still has pieces of transvaginal mesh embedded inside her.
A prominent association of healthcare computer experts has a new set of recommendations to address challenges clinicians face as they're expected to do more with electronic health-record systems.
Drugmaker Teva Pharmaceuticals will pay $1.2 billion to purchasers to settle allegations by the Federal Trade Commission that a company it acquired stalled generic versions of its popular sleep-disorder drug Provigil from entering the market.